(Q30379899)

English

Immunogenicity and tolerability of an AS03(A)-adjuvanted prepandemic influenza vaccine: a phase III study in a large population of Asian adults.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Immunogenicity and tolerability of an AS03(A)-adjuvanted prepandemic influenza vaccine: a phase III study in a large population of Asian adults. (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

1 reference

based on heuristic

inferred from title

influenza vaccine

1 reference

based on heuristic

inferred from title

9

object named as

Paul Gillard

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

8

object named as

Mamadou Dramé

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

author name string

Daniel Wai-Sing Chu

1

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Shinn-Jang Hwang

2

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Fong Seng Lim

3

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Helen May Lin Oh

4

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Prasert Thongcharoen

5

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Pan-Chyr Yang

6

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Hans L Bock

7

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Yanee Hutagalung

10

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Haiwen Tang

11

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Yee Leong Teoh

12

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Ripley W Ballou

13

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

H5N1 Flu Study Group for Hong Kong, Singapore, Taiwan and Thailand

14

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

language of work or name

0 references

publication date

13 August 2009

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

52

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

7428-7435

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Influenza viruses and the evolution of avian influenza virus H5N1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.102

7 January 2021

Bird flu: if or when? Planning for the next pandemic.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.102

7 January 2021

Origin and evolution of the 1918 "Spanish" influenza virus hemagglutinin gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.102

7 January 2021

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.102

7 January 2021

Broad Clade 2 cross-reactive immunity induced by an adjuvanted clade 1 rH5N1 pandemic influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.102

7 January 2021

Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.102

7 January 2021

Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.102

7 January 2021

H5N1 vaccine hits the target, but not the bull's eye

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.102

7 January 2021

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.102

7 January 2021

Strategies for mitigating an influenza pandemic

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.102

7 January 2021

Mitigation strategies for pandemic influenza in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.102

7 January 2021

Identifiers

10.1016/J.VACCINE.2009.07.102

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

release_eicmtfys7rejhosaftux3zzltu

1 reference

https://api.fatcat.wiki/v0/release/eicmtfys7rejhosaftux3zzltu

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30379899&oldid=1953746205"